 | • レポートコード：MR2211MG10683 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：医療 |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、細胞治療及び再生医療のグローバル市場規模と予測を記載しています。・細胞治療及び再生医療のグローバル市場：売上、2017年-2022年、2023年-2028年 ・細胞治療及び再生医療のグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 細胞治療及び再生医療のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「NK細胞療法」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 細胞治療及び再生医療のグローバル主要企業は、DePuy Synthes、 Medtronic、 ZimmerBiomet、 Stryker、 Acelity、 MiMedx Group、 Organogenesis、 UniQure、 Cellular Dynamics International、 Osiris Therapeutics、 Vcanbio、 Gamida Cell、 Golden Meditech、 Cytori、 Celgene、 Vericel Corporation、 Guanhao Biotech、 Mesoblast、 Stemcell Technologies、 Bellicum Pharmaceuticalsなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、細胞治療及び再生医療のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の細胞治療及び再生医療市場：タイプ別、2017年-2022年、2023年-2028年 世界の細胞治療及び再生医療市場：タイプ別市場シェア、2021年 ・NK細胞療法、CAR-T細胞療法、その他 世界の細胞治療及び再生医療市場：用途別、2017年-2022年、2023年-2028年 世界の細胞治療及び再生医療市場：用途別市場シェア、2021年 ・皮膚科、循環器科、中枢神経系、形成外科、その他の医療応用 世界の細胞治療及び再生医療市場：地域・国別、2017年-2022年、2023年-2028年 世界の細胞治療及び再生医療市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における細胞治療及び再生医療のグローバル売上、2017年-2022年 ・主要企業における細胞治療及び再生医療のグローバル売上シェア、2021年 ・主要企業における細胞治療及び再生医療のグローバル販売量、2017年-2022年 ・主要企業における細胞治療及び再生医療のグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 DePuy Synthes、 Medtronic、 ZimmerBiomet、 Stryker、 Acelity、 MiMedx Group、 Organogenesis、 UniQure、 Cellular Dynamics International、 Osiris Therapeutics、 Vcanbio、 Gamida Cell、 Golden Meditech、 Cytori、 Celgene、 Vericel Corporation、 Guanhao Biotech、 Mesoblast、 Stemcell Technologies、 Bellicum Pharmaceuticals ************************************************************* ・調査・分析レポートの概要 細胞治療及び再生医療市場の定義 市場セグメント 世界の細胞治療及び再生医療市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の細胞治療及び再生医療市場規模 世界の細胞治療及び再生医療市場規模：2021年 VS 2028年 世界の細胞治療及び再生医療市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの細胞治療及び再生医療の売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の細胞治療及び再生医療製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：NK細胞療法、CAR-T細胞療法、その他 細胞治療及び再生医療のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：皮膚科、循環器科、中枢神経系、形成外科、その他の医療応用 細胞治療及び再生医療の用途別グローバル売上・予測 ・地域別市場分析 地域別細胞治療及び再生医療市場規模 2021年と2028年 地域別細胞治療及び再生医療売上・予測 北米市場 - アメリカの細胞治療及び再生医療市場規模2017年-2028年 - カナダの細胞治療及び再生医療市場規模2017年-2028年 - メキシコの細胞治療及び再生医療市場規模2017年-2028年 ヨーロッパ市場 - ドイツの細胞治療及び再生医療市場規模2017年-2028年 - フランスの細胞治療及び再生医療市場規模2017年-2028年 - イギリスの細胞治療及び再生医療市場規模2017年-2028年 - イタリアの細胞治療及び再生医療市場規模2017年-2028年 - ロシアの細胞治療及び再生医療市場規模2017年-2028年 アジア市場 - 中国の細胞治療及び再生医療市場規模2017年-2028年 - 日本の細胞治療及び再生医療市場規模2017年-2028年 - 韓国の細胞治療及び再生医療市場規模2017年-2028年 - 東南アジアの細胞治療及び再生医療市場規模2017年-2028年 - インドの細胞治療及び再生医療市場規模2017年-2028年 南米市場 - ブラジルの細胞治療及び再生医療市場規模2017年-2028年 - アルゼンチンの細胞治療及び再生医療市場規模2017年-2028年 中東・アフリカ市場 - トルコの細胞治療及び再生医療市場規模2017年-2028年 - イスラエルの細胞治療及び再生医療市場規模2017年-2028年 - サウジアラビアの細胞治療及び再生医療市場規模2017年-2028年 - UAEの細胞治療及び再生医療市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） DePuy Synthes、 Medtronic、 ZimmerBiomet、 Stryker、 Acelity、 MiMedx Group、 Organogenesis、 UniQure、 Cellular Dynamics International、 Osiris Therapeutics、 Vcanbio、 Gamida Cell、 Golden Meditech、 Cytori、 Celgene、 Vericel Corporation、 Guanhao Biotech、 Mesoblast、 Stemcell Technologies、 Bellicum Pharmaceuticals ... |
Cell therapy is the use of stem cells or their derivatives to promote the repair of diseased, dysfunctional or damaged tissue. As technology develops, researchers can grow stem cells in the lab to differentiate into specific types of cells such as heart muscle cells, blood cells or nerve cells. This is a type of cell that helps repair damaged tissues or organs.
This report contains market size and forecasts of Cell Therapy Regenerative Medicine in global, including the following market information:
Global Cell Therapy Regenerative Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cell Therapy Regenerative Medicine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cell Therapy Regenerative Medicine companies in 2021 (%)
The global Cell Therapy Regenerative Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
NK Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell Therapy Regenerative Medicine include DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure and Cellular Dynamics International, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cell Therapy Regenerative Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell Therapy Regenerative Medicine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cell Therapy Regenerative Medicine Market Segment Percentages, by Type, 2021 (%)
NK Cell Therapy
CAR-T Cell Therapy
Others
Global Cell Therapy Regenerative Medicine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cell Therapy Regenerative Medicine Market Segment Percentages, by Application, 2021 (%)
Dermatology
Cardiovascular
Central Nervous System
Plastic Surgery
Other Medical Applications
Global Cell Therapy Regenerative Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cell Therapy Regenerative Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell Therapy Regenerative Medicine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cell Therapy Regenerative Medicine revenues share in global market, 2021 (%)
Key companies Cell Therapy Regenerative Medicine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cell Therapy Regenerative Medicine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals
1 Introduction to Research & Analysis Reports
1.1 Cell Therapy Regenerative Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell Therapy Regenerative Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell Therapy Regenerative Medicine Overall Market Size
2.1 Global Cell Therapy Regenerative Medicine Market Size: 2021 VS 2028
2.2 Global Cell Therapy Regenerative Medicine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Cell Therapy Regenerative Medicine Sales: 2017-2028
3 Company Landscape
3.1 Top Cell Therapy Regenerative Medicine Players in Global Market
3.2 Top Global Cell Therapy Regenerative Medicine Companies Ranked by Revenue
3.3 Global Cell Therapy Regenerative Medicine Revenue by Companies
3.4 Global Cell Therapy Regenerative Medicine Sales by Companies
3.5 Global Cell Therapy Regenerative Medicine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Cell Therapy Regenerative Medicine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Cell Therapy Regenerative Medicine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cell Therapy Regenerative Medicine Players in Global Market
3.8.1 List of Global Tier 1 Cell Therapy Regenerative Medicine Companies
3.8.2 List of Global Tier 2 and Tier 3 Cell Therapy Regenerative Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Cell Therapy Regenerative Medicine Market Size Markets, 2021 & 2028
4.1.2 NK Cell Therapy
4.1.3 CAR-T Cell Therapy
4.1.4 Others
4.2 By Type – Global Cell Therapy Regenerative Medicine Revenue & Forecasts
4.2.1 By Type – Global Cell Therapy Regenerative Medicine Revenue, 2017-2022
4.2.2 By Type – Global Cell Therapy Regenerative Medicine Revenue, 2023-2028
4.2.3 By Type – Global Cell Therapy Regenerative Medicine Revenue Market Share, 2017-2028
4.3 By Type – Global Cell Therapy Regenerative Medicine Sales & Forecasts
4.3.1 By Type – Global Cell Therapy Regenerative Medicine Sales, 2017-2022
4.3.2 By Type – Global Cell Therapy Regenerative Medicine Sales, 2023-2028
4.3.3 By Type – Global Cell Therapy Regenerative Medicine Sales Market Share, 2017-2028
4.4 By Type – Global Cell Therapy Regenerative Medicine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Cell Therapy Regenerative Medicine Market Size, 2021 & 2028
5.1.2 Dermatology
5.1.3 Cardiovascular
5.1.4 Central Nervous System
5.1.5 Plastic Surgery
5.1.6 Other Medical Applications
5.2 By Application – Global Cell Therapy Regenerative Medicine Revenue & Forecasts
5.2.1 By Application – Global Cell Therapy Regenerative Medicine Revenue, 2017-2022
5.2.2 By Application – Global Cell Therapy Regenerative Medicine Revenue, 2023-2028
5.2.3 By Application – Global Cell Therapy Regenerative Medicine Revenue Market Share, 2017-2028
5.3 By Application – Global Cell Therapy Regenerative Medicine Sales & Forecasts
5.3.1 By Application – Global Cell Therapy Regenerative Medicine Sales, 2017-2022
5.3.2 By Application – Global Cell Therapy Regenerative Medicine Sales, 2023-2028
5.3.3 By Application – Global Cell Therapy Regenerative Medicine Sales Market Share, 2017-2028
5.4 By Application – Global Cell Therapy Regenerative Medicine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Cell Therapy Regenerative Medicine Market Size, 2021 & 2028
6.2 By Region – Global Cell Therapy Regenerative Medicine Revenue & Forecasts
6.2.1 By Region – Global Cell Therapy Regenerative Medicine Revenue, 2017-2022
6.2.2 By Region – Global Cell Therapy Regenerative Medicine Revenue, 2023-2028
6.2.3 By Region – Global Cell Therapy Regenerative Medicine Revenue Market Share, 2017-2028
6.3 By Region – Global Cell Therapy Regenerative Medicine Sales & Forecasts
6.3.1 By Region – Global Cell Therapy Regenerative Medicine Sales, 2017-2022
6.3.2 By Region – Global Cell Therapy Regenerative Medicine Sales, 2023-2028
6.3.3 By Region – Global Cell Therapy Regenerative Medicine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Cell Therapy Regenerative Medicine Revenue, 2017-2028
6.4.2 By Country – North America Cell Therapy Regenerative Medicine Sales, 2017-2028
6.4.3 US Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.4.4 Canada Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.4.5 Mexico Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Cell Therapy Regenerative Medicine Revenue, 2017-2028
6.5.2 By Country – Europe Cell Therapy Regenerative Medicine Sales, 2017-2028
6.5.3 Germany Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5.4 France Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5.5 U.K. Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5.6 Italy Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5.7 Russia Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5.8 Nordic Countries Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.5.9 Benelux Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Cell Therapy Regenerative Medicine Revenue, 2017-2028
6.6.2 By Region – Asia Cell Therapy Regenerative Medicine Sales, 2017-2028
6.6.3 China Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.6.4 Japan Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.6.5 South Korea Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.6.6 Southeast Asia Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.6.7 India Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Cell Therapy Regenerative Medicine Revenue, 2017-2028
6.7.2 By Country – South America Cell Therapy Regenerative Medicine Sales, 2017-2028
6.7.3 Brazil Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.7.4 Argentina Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Cell Therapy Regenerative Medicine Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Cell Therapy Regenerative Medicine Sales, 2017-2028
6.8.3 Turkey Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.8.4 Israel Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.8.5 Saudi Arabia Cell Therapy Regenerative Medicine Market Size, 2017-2028
6.8.6 UAE Cell Therapy Regenerative Medicine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 DePuy Synthes
7.1.1 DePuy Synthes Corporate Summary
7.1.2 DePuy Synthes Business Overview
7.1.3 DePuy Synthes Cell Therapy Regenerative Medicine Major Product Offerings
7.1.4 DePuy Synthes Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.1.5 DePuy Synthes Key News
7.2 Medtronic
7.2.1 Medtronic Corporate Summary
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Cell Therapy Regenerative Medicine Major Product Offerings
7.2.4 Medtronic Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.2.5 Medtronic Key News
7.3 ZimmerBiomet
7.3.1 ZimmerBiomet Corporate Summary
7.3.2 ZimmerBiomet Business Overview
7.3.3 ZimmerBiomet Cell Therapy Regenerative Medicine Major Product Offerings
7.3.4 ZimmerBiomet Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.3.5 ZimmerBiomet Key News
7.4 Stryker
7.4.1 Stryker Corporate Summary
7.4.2 Stryker Business Overview
7.4.3 Stryker Cell Therapy Regenerative Medicine Major Product Offerings
7.4.4 Stryker Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.4.5 Stryker Key News
7.5 Acelity
7.5.1 Acelity Corporate Summary
7.5.2 Acelity Business Overview
7.5.3 Acelity Cell Therapy Regenerative Medicine Major Product Offerings
7.5.4 Acelity Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.5.5 Acelity Key News
7.6 MiMedx Group
7.6.1 MiMedx Group Corporate Summary
7.6.2 MiMedx Group Business Overview
7.6.3 MiMedx Group Cell Therapy Regenerative Medicine Major Product Offerings
7.6.4 MiMedx Group Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.6.5 MiMedx Group Key News
7.7 Organogenesis
7.7.1 Organogenesis Corporate Summary
7.7.2 Organogenesis Business Overview
7.7.3 Organogenesis Cell Therapy Regenerative Medicine Major Product Offerings
7.7.4 Organogenesis Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.7.5 Organogenesis Key News
7.8 UniQure
7.8.1 UniQure Corporate Summary
7.8.2 UniQure Business Overview
7.8.3 UniQure Cell Therapy Regenerative Medicine Major Product Offerings
7.8.4 UniQure Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.8.5 UniQure Key News
7.9 Cellular Dynamics International
7.9.1 Cellular Dynamics International Corporate Summary
7.9.2 Cellular Dynamics International Business Overview
7.9.3 Cellular Dynamics International Cell Therapy Regenerative Medicine Major Product Offerings
7.9.4 Cellular Dynamics International Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.9.5 Cellular Dynamics International Key News
7.10 Osiris Therapeutics
7.10.1 Osiris Therapeutics Corporate Summary
7.10.2 Osiris Therapeutics Business Overview
7.10.3 Osiris Therapeutics Cell Therapy Regenerative Medicine Major Product Offerings
7.10.4 Osiris Therapeutics Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.10.5 Osiris Therapeutics Key News
7.11 Vcanbio
7.11.1 Vcanbio Corporate Summary
7.11.2 Vcanbio Cell Therapy Regenerative Medicine Business Overview
7.11.3 Vcanbio Cell Therapy Regenerative Medicine Major Product Offerings
7.11.4 Vcanbio Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.11.5 Vcanbio Key News
7.12 Gamida Cell
7.12.1 Gamida Cell Corporate Summary
7.12.2 Gamida Cell Cell Therapy Regenerative Medicine Business Overview
7.12.3 Gamida Cell Cell Therapy Regenerative Medicine Major Product Offerings
7.12.4 Gamida Cell Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.12.5 Gamida Cell Key News
7.13 Golden Meditech
7.13.1 Golden Meditech Corporate Summary
7.13.2 Golden Meditech Cell Therapy Regenerative Medicine Business Overview
7.13.3 Golden Meditech Cell Therapy Regenerative Medicine Major Product Offerings
7.13.4 Golden Meditech Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.13.5 Golden Meditech Key News
7.14 Cytori
7.14.1 Cytori Corporate Summary
7.14.2 Cytori Business Overview
7.14.3 Cytori Cell Therapy Regenerative Medicine Major Product Offerings
7.14.4 Cytori Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.14.5 Cytori Key News
7.15 Celgene
7.15.1 Celgene Corporate Summary
7.15.2 Celgene Business Overview
7.15.3 Celgene Cell Therapy Regenerative Medicine Major Product Offerings
7.15.4 Celgene Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.15.5 Celgene Key News
7.16 Vericel Corporation
7.16.1 Vericel Corporation Corporate Summary
7.16.2 Vericel Corporation Business Overview
7.16.3 Vericel Corporation Cell Therapy Regenerative Medicine Major Product Offerings
7.16.4 Vericel Corporation Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.16.5 Vericel Corporation Key News
7.17 Guanhao Biotech
7.17.1 Guanhao Biotech Corporate Summary
7.17.2 Guanhao Biotech Business Overview
7.17.3 Guanhao Biotech Cell Therapy Regenerative Medicine Major Product Offerings
7.17.4 Guanhao Biotech Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.17.5 Guanhao Biotech Key News
7.18 Mesoblast
7.18.1 Mesoblast Corporate Summary
7.18.2 Mesoblast Business Overview
7.18.3 Mesoblast Cell Therapy Regenerative Medicine Major Product Offerings
7.18.4 Mesoblast Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.18.5 Mesoblast Key News
7.19 Stemcell Technologies
7.19.1 Stemcell Technologies Corporate Summary
7.19.2 Stemcell Technologies Business Overview
7.19.3 Stemcell Technologies Cell Therapy Regenerative Medicine Major Product Offerings
7.19.4 Stemcell Technologies Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.19.5 Stemcell Technologies Key News
7.20 Bellicum Pharmaceuticals
7.20.1 Bellicum Pharmaceuticals Corporate Summary
7.20.2 Bellicum Pharmaceuticals Business Overview
7.20.3 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Major Product Offerings
7.20.4 Bellicum Pharmaceuticals Cell Therapy Regenerative Medicine Sales and Revenue in Global (2017-2022)
7.20.5 Bellicum Pharmaceuticals Key News
8 Global Cell Therapy Regenerative Medicine Production Capacity, Analysis
8.1 Global Cell Therapy Regenerative Medicine Production Capacity, 2017-2028
8.2 Cell Therapy Regenerative Medicine Production Capacity of Key Manufacturers in Global Market
8.3 Global Cell Therapy Regenerative Medicine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cell Therapy Regenerative Medicine Supply Chain Analysis
10.1 Cell Therapy Regenerative Medicine Industry Value Chain
10.2 Cell Therapy Regenerative Medicine Upstream Market
10.3 Cell Therapy Regenerative Medicine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cell Therapy Regenerative Medicine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer